Inhibition of <scp>DDR</scp> 1‐ <scp>BCR</scp> signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
2018 · EMBO Molecular Medicine · 109 citations
https://doi.org/10.15252/emmm.201707918
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
169
Citations
4
h-index
2
i10-index
Priscillia Tosti is an academic researcher. The author has contributed to research in topics: Cervical Cancer and HPV Research & Animal Virus Infections Studies & Virus-based gene therapy research. The author has an h-index of 4, co-authored 13 publications.
Click to start Chat